The Food and Drug Administration on Friday approved Eli Lillys weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first … [+2963 chars]Read More
FDA approves weightloss drug Zepbound to treat sleep apnea The Washington Post
